Parametrica Management LTD Sage Therapeutics, Inc. Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$157.85 - $183.09 $251,928 - $292,211	-1,596 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$89.33 - $163.65 $142,570 - $261,185	1,596 New	1,596 $254,000
Q1 2018 Apr 24, 2018	SELL	$152.15 - $192.33 $526,895 - $666,038	-3,463 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$60.72 - $167.34 $210,273 - $579,498	3,463	3,463 $570,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.